Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 990 of 5804
-
Can skipping opioids during surgery curb addiction? new trial aims to find out
Disease control TerminatedIn the current opioid crisis, the use of opioids as the main pain management method is recognized as a consistent risk factor for chronic opioid use and the development of Opioid Use Disorder (OUD), as well as related complications like overdose fatalities among surgical patients…
Phase: EARLY_PHASE1 • Sponsor: Jacques E. Chelly • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Magnetic pulses to the brain could help depressed patients think more clearly
Symptom relief Not yet recruitingMajor depressive disorder (MDD) often involves cognitive deficits, particularly in cognitive flexibility, which is inadequately addressed by standard antidepressants. This study tests an innovative brain stimulation regimen: individualized dual-target repetitive transcranial magn…
Phase: NA • Sponsor: Second Xiangya Hospital of Central South University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New combo attack on lung tumors: immunotherapy, radiation, and surgery
Disease control Recruiting nowThis study aims to determine the safety and tolerability of combined Atezolizumab, stereotactic body radiation therapy (SBRT), and surgical resection of pulmonary metastases in patients with pulmonary recurrence of osteosarcoma
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a fatty acid drug stop dangerous sugar crashes in rare disease?
Disease control TerminatedThis is a medical research study to test a medication in patients 4 years of age and older with a disease called medium-chain acyl-CoA dehydrogenase deficiency (MCADD). The medication is triheptanoin, which is currently FDA approved for the treatment of long chain fatty acid oxid…
Phase: PHASE2 • Sponsor: Jerry Vockley, MD, PhD • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Stem cell injection aims to repair kidneys in diabetes patients
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and efficacy of a single intra-renal injection of allogeneic umbilical cord-derived mesenchymal stem cells (UC-MSCs) in adults with diabetic nephropathy aged 40 to 65 years. The primary questions the study aims to answer a…
Phase: PHASE1, PHASE2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Blood test may replace needle biopsies for prostate cancer watch
Knowledge-focused Not yet recruitingThe CHAS3 trial studies whether the Stockholm3 blood test can reliably detect if prostate cancer becomes more aggressive in men who are being carefully monitored instead of treated right away (active surveillance). The goal is to see if this test can help doctors safely follow pa…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Personalized cancer test could take guesswork out of treatment
Knowledge-focused Not yet recruitingThe ColoPan study evaluates the scientific validity, reproducibility, and predictive performance of the Personalised Functional Profiling (PFP) platform in colorectal cancer and pancreatic ductal adenocarcinoma patients. It combines genomic sequencing with in vitro functional dru…
Sponsor: Luxembourg Institute of Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New study aims to find best talk therapy for traumatized teens with chronic illness
Symptom relief Not yet recruitingThe goal of this clinical trial is to compare the effectiveness of trauma-focused therapies for improving mental health symptoms and daily functioning in youth with chronic medical conditions who have experienced psychological trauma and trauma-related distress. The study evaluat…
Phase: NA • Sponsor: Anthony Vesco • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Heart attack survivors: shorter blood thinner course may be safer and effective
Disease control Not yet recruitingThis study is testing different blood-thinning treatment strategies for people who have had a heart attack and were successfully treated with a coronary stent procedure (PCI). All strategies tested are already approved for this condition and used inversally. This study will defin…
Phase: PHASE4 • Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Brain training app takes on long COVID disability
Symptom relief Not yet recruitingThe goal of this study is to determine whether the SuperCAP intervention program is superior to control in reducing disability from baseline to the post-intervention assessment in people with Post-COVID-19 Condition. The main question it aims to answer is whether participants as…
Phase: NA • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
New antibiotic strategy could shorten hospital stays for heart infections
Disease control Not yet recruitingCardiac infections, including infective endocarditis and cardiovascular implantable electronic device infections, are associated with substantial morbidity and mortality and are commonly caused by gram-positive bacteria. Standard management typically requires prolonged courses of…
Phase: PHASE2 • Sponsor: Kirby Institute • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Remote exercise program aims to boost chemo completion in cancer patients
Symptom relief Not yet recruitingThis study will evaluate whether a remotely delivered exercise program can improve chemotherapy tolerability in patients with gastrointestinal or lung cancer receiving chemotherapy. In this decentralized, digital randomized clinical trial, up to 120 adults with gastrointestinal …
Phase: NA • Sponsor: AdventHealth Translational Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New pill may boost insulin pump performance in type 1 diabetes
Disease control Not yet recruitingTTP399-206 is a Phase 2a multicenter double blind cross over randomized study of cadisegliatin in participants with T1D using hybrid closed loop systems to manager their diabetes. Patients using a hybrid closed loop insulin pump to manage their diabetes will be randomized to eith…
Phase: PHASE2 • Sponsor: vTv Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Engineered immune cells take on Hard-to-Treat sarcomas
Disease control Recruiting nowThe aim of this clinical trial is to assess the feasibility, safety and efficacy of a combination low dose chemotherapy and immunotherapy in patients who have sarcoma that is relapsed or late staged. Another goal of the study is to assess the safety and efficacy of the therapy th…
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New combo therapy aims to boost platelets in ITP patients
Disease control Not yet recruitingThis is a prospective, randomized, controlled trial. ITP patients who failed prior full-does TPO-RA monotheray for 14 days. Patients are randomly assigned at a 1:1 ratio to receive baricitinib plus TPO-RA or TPO-RA alone. Patients are randomly assigned at a 1:1 ratio to receive b…
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Oral asthma drug KT-621 tested for Long-Term safety
Disease control Recruiting nowThis Phase 2b open-label, long-term extension study is designed to evaluate the long-term safety and efficacy of KT-621 in participants with asthma who were previously enrolled in the parent study (KT621-AS-202) of KT-621 for asthma. The main goals of this study are to investigat…
Phase: PHASE2 • Sponsor: Kymera Therapeutics, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New antibody drug targets Hard-to-Treat cancers
Disease control Not yet recruitingThis study is an open-label, multicenter, non-randomized Phase I clinical study with dose-escalation and expansion cohorts, designed to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of SI-B036 bispecific antibody injection in patient…
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can a daily supplement help the body fight off HPV?
Disease control Not yet recruitingThis interventional, single-center, open-label randomized clinical study evaluates the efficacy of an oral dietary supplement (Pervistop®) in women with persistent Human Papillomavirus (HPV) infection. The supplement is a combination of four natural molecules: Epigallocatechin ga…
Phase: NA • Sponsor: IRCCS San Raffaele • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a gentle ear zap boost physiotherapy for a mysterious brain disorder?
Symptom relief Not yet recruitingThis clinical study will test if adding a non-invasive stimulation of the vagus nerve through the ear during physiotherapy brings an improvement to FND (Functional Neurological Disorder) patients with motor symptoms. First, the investigators will test the normal functioning of t…
Phase: NA • Sponsor: University of Fribourg • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Brain zaps during surgery may ease Post-Op anxiety
Symptom relief Not yet recruitingThe incidence of postoperative anxiety in surgery ranges from 4.1% to 79.6% , and among patients undergoing intraspinal tumor resection surgery, the incidence of postoperative anxiety is as high as 46.7%.Adverse effects induced by anxiety include insomnia, exacerbated pain, impai…
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC